InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Miller Andrew Craig, Executive. Officer active across 2 companies, notably Karuna Therapeutics, Inc.. Cumulatively, 15 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €230k. History available since 10 May 2021. The latest transaction was filed on 24 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Miller Andrew Craig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
11,006 shares0Common StockSEC:0001193125-26-091626:0
13,977 shares@ US$330.0073.7% of flowCommon StockSEC:0001140361-24-013930:0
1,011 shares@ US$317.145.2% of flowCommon StockSEC:0000950170-24-013962:0
30,000 shares@ US$9.204.4% of flowCommon StockSEC:0000950170-23-013722:0
12,550 shares0Common StockSEC:0001593968-23-000302:0
7,100 shares@ US$2.920.3% of flowCommon StockSEC:0001593968-22-001764:0
250 shares@ US$7.270.0% of flowCommon StockSEC:0001593968-22-001691:0
1,000 shares@ US$7.270.1% of flowCommon StockSEC:0001593968-22-001596:0
2,000 shares@ US$2.920.1% of flowCommon StockSEC:0001593968-22-001570:0
26,500 shares@ US$2.921.3% of flowCommon StockSEC:0001593968-21-002357:0
700 shares@ US$118.551.4% of flowCommon StockSEC:0001593968-21-002238:0
1,590 shares@ US$117.873.0% of flowCommon StockSEC:0001593968-21-002085:0
12,500 shares@ US$2.920.6% of flowCommon StockSEC:0001593968-21-001993:0
13,333 shares@ US$9.201.9% of flowCommon StockSEC:0001593968-21-001617:0
5,000 shares@ US$9.200.7% of flowCommon StockSEC:0001593968-21-001293:0
15 of 15 declarations
About Miller Andrew Craig
Miller Andrew Craig is an executive linked to Karuna Therapeutics, Inc., where he is President of R&D, and to Kyverna Therapeutics, Inc., where he is Director. He has 15 filings in total, and across the recent filings observed, the transactions cover the period from 2021-05-12 to 2026-03-04, with 0 in buys and 4468316 in sells; the most frequent transaction nature is Option exercise.
